Issue 65 of the research*eu Results Magazine – Stemming the blood cancer tide
September is Blood Cancer Awareness Month: an occasion for spreading information about this group of diseases affecting the blood, bone marrow or lymphatic system. Every 35 seconds, a new patient is diagnosed with either leukaemia, lymphoma or myeloma — the three main types of blood cancers. Most cancers in these sub-groups require specific and complex therapeutic strategies, yet, despite continuous scientific advances, most of them are still fatal. There are, however, reasons to think positive. Since the 1960s, survival rates over five years have grown from 12 to 50% for myeloma, 40 to 89% for Hodgkin lymphoma, 31 to 73% for non-Hodgkin lymphoma, and 14 to 63% for leukaemia. Haematologic oncology is rapidly evolving, and exciting treatment options are emerging thanks partly to EU-funded research efforts. A great example of these advances is the cure found for acute promyelocytic leukaemia (APL). Through a combination of arsenic and retinoic acid discovered by Prof. de The — whose latest research is presented in this issue of the research*eu Results Magazine — over 95% of patients faced with this formerly incurable disease can now be cured. Apart from these novel treatments — which include CARIPSCTCELLS off-the-shelf T cell therapies for multiple myeloma and HEAL-BY-MIRNAs miRNA-based cure for B cell neoplasia —EU-funded research also helps shape the future of blood cancer therapies. It does so by opening the path towards increasingly personalised treatments (ONCOSMART, CHEMOS), facilitating clinical trials (INTREALL) or unveiling the processes driving cancer evolution (CLL_INCLONEL). Other topics in this edition include the following highlights: - Oral immunotherapy for cystic fibrosis - Expanding the preventative archaeology toolbox in Eastern Europe - New grids on the block: Sparking the energy evolution - Improved predictions for weather and climate - New recommendations for growth of organic aquaculture - ‘Sensitive’ buildings adapt to changes - Combining operational and analytical databases in a single platform - Innovative method and technological solutions to foil cyberattacks on utility companies - Graphene-based spintronics for next-gen molecular electronic devices The research*eu Results Magazine is the main source of information for all findings related to EU-funded science projects. It covers a large spectrum of scientific topics and is published 10 times per year in English. For more information, sign up for a free subscription and to download the new edition, please visit: http://cordis.europa.eu/research-eu/home_en.html(opens in new window)
Countries
Austria, Belgium, Bulgaria, Cyprus, Czechia, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Croatia, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia, United Kingdom